Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Chu

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|March 29, 2000
Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogensY S Or, R F Clark, S Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivativesR F Clark, Z Ma, S Wang, et al.
Diabetologia|November 1, 1994
Expression of human GLUT4 in mice results in increased insulin actionR O Deems, J L Evans, R W Deacon, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analoguesG Griesgraber, M J Kramer, R L Elliott, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 positionZ Ma, D T Chu, C S Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and structure-activity relationships of 2-pyridones: II. 8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agentsQ Li, W Wang, K B Berst, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analoguesR L Elliott, D Pireh, G Griesgraber, et al.
Neoplasma|June 25, 2013
Individualized treatment of NSCLC: from research to clinical practiceY Wang, Z D Liu, L M Zhao, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|March 29, 2000
Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogensY S Or, R F Clark, S Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivativesR F Clark, Z Ma, S Wang, et al.
Diabetologia|November 1, 1994
Expression of human GLUT4 in mice results in increased insulin actionR O Deems, J L Evans, R W Deacon, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analoguesG Griesgraber, M J Kramer, R L Elliott, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 positionZ Ma, D T Chu, C S Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and structure-activity relationships of 2-pyridones: II. 8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agentsQ Li, W Wang, K B Berst, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analoguesR L Elliott, D Pireh, G Griesgraber, et al.
Neoplasma|June 25, 2013
Individualized treatment of NSCLC: from research to clinical practiceY Wang, Z D Liu, L M Zhao, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Pageof 9